Related references
Note: Only part of the references are listed.PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers
I. A. Ivens et al.
HAEMOPHILIA (2013)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Volker Schellenberger et al.
NATURE BIOTECHNOLOGY (2009)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C
A Kozlowski et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Share Paper
